NSE · ERIS.NS
Eris Lifesciences Limited
₹1,169.10+₹5.50 (+0.47%)
Eris Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 32.81% below the high.
Loading market information…
NSE · BLISSGVS.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:07 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Bliss GVS Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 11.74% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Bliss GVS Pharma Limited’s forward annual dividend is ₹2.00 per share, paid semi-annual. The forward yield is 0.31% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bliss GVS Pharma Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1984 and headquartered in Mumbai, India, Bliss GVS Pharma Limited specializes in the development, manufacturing, and distribution of a comprehensive array of pharmaceutical products. The company's pharmaceutical portfolio includes an extensive range of dosage forms, such as oral solids (tablets, capsules), various liquid and injectable preparations, topical applications (creams, gels), and advanced drug delivery systems like transdermal patches. Beyond conventional medicines, Bliss GVS also offers a diverse selection of other healthcare and personal care items, including balms, lotions, shampoos, and over-the-counter remedies. Their therapeutic focus is equally broad, encompassing solutions for anti-infectives, pain management, gastrointestinal issues, anti-malarials, dermatological conditions, nutritional support, and a wide variety of other wellness and hygiene products, including medicated and cosmetic soaps. The company actively engages in international exports, extending its market presence beyond India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,169.10+₹5.50 (+0.47%)
Eris Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 32.81% below the high.
₹727.95-₹13.10 (-1.77%)
Akums Drugs & Pharmaceuticals Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.22% below the high.
₹1,030.70-₹20.40 (-1.94%)
Innova Captab Limited’s quoted price sits in the upper half of its reported 52-week range, 23.85% below the high.
₹949.20+₹2.70 (+0.29%)
Sakar Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 22.82% below the high.
₹206.05-₹3.45 (-1.65%)
Indoco Remedies Limited’s quoted price sits in the lower half of its reported 52-week range, 28.47% below the high.
₹19.46-₹0.95 (-4.65%)
Syncom Formulations (India) Limited’s quoted price sits in the upper half of its reported 52-week range, 29.1% below the high.
₹1,250.00-₹39.30 (-3.05%)
Venus Remedies Limited’s quoted price sits in the upper half of its reported 52-week range, 38.85% below the high.
₹217.22-₹4.72 (-2.13%)
Jagsonpal Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 17.67% below the high.
